Alerts in the last 24 hours

No Personalised Alerts!

To see personalised alerts you need to be logged in.

Log In

McKesson Corp Add to portfolio

INX:MCK, May 20, 11:35 UTC

Latest INX:MCK News

Filter your feed

Apply Filter

Today


News

Moon Capital Management LLC Boosted Position in Mckesson Corp (MCK) by $3.12 Million as Market Value Declined

MCK

Farmers Bank & Trust owns 0.03% invested in McKesson Corporation (NYSE:MCK) for 134 shares. Since December 14, 2017, it had 0 buys, and 2 insider sales for $10.61 million activity. The institutional investor held 30,319 shares of the other pharmaceuticals company at the end of 2017Q4, valued at $4.73 billion, up from 30,299 at the end of the previous reported quarter. Moon Capital Management Llc, which manages about $166.36M and $97.61B US Long portfolio, decreased its stake in Monsanto Co (NYSE:MON) by 210 shares to 18,827 shares, valued at $2.20 billion in 2017Q4, according to the filing. More important recent McKesson Corporation (NYSE:MCK) news were published by: Seekingalpha.com which released: “McKesson launches growth initiative, sees non-GAAP EPS as high as $12.80” on April 25, 2018, also Seekingalpha.com published article titled: “More states sue over opioid epidemic”, Streetinsider.com published: “Rite Aid (RAD)/Albertsons More Likely to Depart McKesson (MCK), a Positive for AmerisourceBergen (ABC) – RBC” on May 15, 2018.

Read Full Details

Topics:
  • Business
  • Financial
  • Science

Friday, May 18


News

$3.54 EPS Expected for McKesson Corporation (MCK)

MCK

It is negative, as 73 investors sold McKesson Corporation shares while 310 reduced holdings. Gabelli Funds Lc holds 0.05% of its portfolio in McKesson Corporation (NYSE:MCK) for 55,000 shares. Amer Century Companies has invested 0.2% in McKesson Corporation (NYSE:MCK). Oregon Pub Employees Retirement Fund reported 86,807 shares. Diamond Hill Capital Mgmt Incorporated has invested 0% in McKesson Corporation (NYSE:MCK). Since December 14, 2017, it had 0 insider buys, and 2 sales for $10.61 million activity.

Read Full Details

Topics:
  • Business
  • Health
  • Technology
  • Science
  • Financial
News

McKesson (NYSE:MCK) Issues FY19 Earnings Guidance

MCK

The company provided earnings per share guidance of $13.00 -13.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $13.37. Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter. The company has a market capitalization of $30.98 billion, a P/E ratio of 11.97, a price-to-earnings-growth ratio of 1.38 and a beta of 1.31. Finally, Zacks Investment Research raised shares of McKesson from a hold rating to a buy rating and set a $189.00 target price on the stock in a research note on Friday, February 2nd.

Read Full Details

Topics:
  • Business
  • Financial

Wednesday, May 16


News

Jacobs Asset Management Has Decreased Its Hancock Hldg Co (HBHC) Stake by $6.48 Million; As Nordstrom (JWN) Stock Price Declined, Mkp Capital Management Has Lowered Its Position by $4.56 Million

MCK JWN

The stock increased 1.32% or $0.66 during the last trading session, reaching $50.52. About 1.49 million shares traded. Nordstrom, Inc. (NYSE:JWN) has risen 11.56% since May 16, 2017 and is uptrending. The institutional investor held 3.61 million shares of the other pharmaceuticals company at the end of 2017Q4, valued at $563.35 million, up from 3.31 million at the end of the previous reported quarter. Among 31 analysts covering Nordstrom Inc. (NYSE:JWN), 6 have Buy rating, 6 Sell and 19 Hold. Therefore 19% are positive. Nordstrom Inc. had 116 analyst reports since August 14, 2015 according to SRatingsIntel.

Read Full Details

Topics:
  • Business
  • Financial
News

Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug

MCK

THE WOODLANDS, Texas--(BUSINESS WIRE)--A powerful, real-world evidence study designed by McKesson Specialty Health for its biopharma partner played a key role in the Food and Drug Administration’s (FDA) approval for first-line indication for a rare disease. The award acknowledges excellence in health economics and outcomes research (HEOR), a strategic focus for the company, and was announced at an award ceremony with organizers Pharma Intelligence, biopharma companies, researchers, and providers last month in Boston. “Real-world evidence is increasingly being leveraged to support FDA approvals, enabling more therapy options to advance and optimize cancer care,” said Nicholas Robert, M.D., Medical Director, Health Economic and Outcomes Research/Health Informatics, McKesson Specialty Health and The US Oncology Network. McKesson Specialty Health (“MSH”), a division of McKesson Corporation, works together with stakeholders across the healthcare delivery system to preserve and strengthen specialty care, passionately driven by the benefits it provides patients and the system as a whole.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
News

Will Core Distribution Unit Aid McKesson (MCK) Q4 Earnings?

MCK

McKesson Corporation’s MCK fourth-quarter fiscal 2018 earnings are scheduled to release on May 24, before the market opens. While results are likely to show growth in the core Distribution Solutions segment, other initiatives may also drive earnings. McKesson’s fiscal third-quarter performance was promising, with adjusted earnings of $3.41 per share beating the Zacks Consensus Estimate by 16.8%. Notably, McKesson has a positive average earnings surprise of 8.5% for the trailing four quarters. McKesson Corporation Price and EPS Surprise | McKesson Corporation Quote. For the quarter to be reported, the Zacks Consensus Estimate for the segment’s revenues is pegged at $52.11 billion, reflecting a 8.1% rise from the prior-year quarter.

Read Full Details

Topics:
  • Business
  • Financial

Tuesday, May 15


News

McKesson High Volume Solutions and Discount Drug Mart Partner to Build a Central Fill Pharmacy - Press Release

MCK

McKesson High Volume Solutions and Discount Drug Mart Partner to Build a Central Fill Pharmacy Print Create a hardcopy of this page Font Size: Default font size Larger font size. MALVERN, Pa.--(BUSINESS WIRE)--May 15, 2018--McKesson High Volume Solutions (HVS) is pleased to announce a pharmacy automation agreement with Discount Drug Mart, Inc., an Ohio-based retail drug store chain that operates more than 70 pharmacies in the state. As part of the deal, McKesson HVS will provide a dispensing automation platform for Discount Drug Mart’s central fill pharmacy to be located in Avon Lake, Ohio. Pharmacy automation from McKesson HVS is an effective way for retail chain and health system pharmacies to fulfill large numbers of prescription orders accurately and efficiently. | Tags: Worldapwirenews, Medical Technology, Technology, Health, Retail And Wholesale, Consumer Services, Consumer Products And Services, Business, Retail Industry, Medication, Diagnosis And Treatment, Pharmacy Operators, Aerospace And Defense Industry, Industrial Products And Services, New Products And Services, Products And Services, Corporate News, Pharmaceutical Manufacturing, Health Care Industry, Health Care Services, Prescription Drug Costs, Health Care Costs.

Read Full Details

Topics:
  • Business
  • Health
  • Financial
  • Science

Monday, May 14


News

These two are the must watch stock’s for the fearless investors: McKesson Corporation (MCK), Dover Corporation (DOV)

MCK DOV

During the key period of last 5 years, McKesson Corporation (NYSE:MCK) sales have annually surged 10.20% on average, however its earnings per share growth remained at 33.50%.How Company Returns Shareholder’s Value? McKesson Corporation (NYSE:MCK) for the trailing twelve months paying dividend with the payout ratio of 5.56% to its shareholders. On the other hand if price drops, the contrary is right. For McKesson Corporation (NYSE:MCK), Stochastic %D value stayed at 16.75% for the last 9 days. A simple moving average (SMA) is an mathematical moving average calculated by adding the closing price of the security for a number of time periods and then dividing this total by the number of time periods.

Read Full Details

Topics:
  • Business
  • Financial

Sunday, May 13


News

Commerzbank Aktiengesellschaft FI Increases Position in McKesson (MCK) – Enterprise Leader

MCK

Commerzbank Aktiengesellschaft FI increased its stake in McKesson (NYSE:MCK) by 17.1% in the 1st quarter, according to its most recent disclosure with the SEC. Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 769 shares of the company’s stock valued at $130,000 after buying an additional 491 shares during the period. Zacks Investment Research upgraded shares of McKesson from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research report on Wednesday, February 14th.

Read Full Details

Topics:
  • Business
  • Financial
News

Reviewing McKesson (MCK) and Nu Skin Enterprises (NYSE:NUS) – Macon Daily

MCK ABC

Nu Skin Enterprises (NYSE: NUS) and AmerisourceBergen (NYSE:ABC) are both consumer staples companies, but which is the better stock? Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter. Nu Skin Enterprises pays an annual dividend of $1.46 per share and has a dividend yield of 1.9%. Nu Skin Enterprises has raised its dividend for 17 consecutive years and AmerisourceBergen has raised its dividend for 13 consecutive years.

Read Full Details

Topics:
  • Business
  • Health
  • Financial